Myasthenia Gravis Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014544344
Market Monitor Global
Oct-2021
Life Sciences
101 Pages

This report contains market size and forecasts of Myasthenia Gravis Drugs in global, including the following market information:
Global Myasthenia Gravis Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Myasthenia Gravis Drugs Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Myasthenia Gravis Drugs companies in 2020 (%)
The global Myasthenia Gravis Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myasthenia Gravis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myasthenia Gravis Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, By Type, 2020 (%)
Anticholinesterases
Immunosuppressants
Intravenous Immune Globulins

Global Myasthenia Gravis Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics

Global Myasthenia Gravis Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myasthenia Gravis Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Myasthenia Gravis Drugs revenues share in global market, 2020 (%)
Key companies Myasthenia Gravis Drugs sales in global market, 2016-2021 (Estimated), (MT)
Key companies Myasthenia Gravis Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Flamel Technologies
F. Hoffmann-La Roche
Grifols
Pfizer
Takeda
Novartis
Bausch Health
Alexion Pharmaceuticals
Catalyst Pharmaceuticals
CSL
Curavac
Cytokinetics
Galencia
GlaxoSmithKline
Lupin Pharmaceuticals
Mitsubishi Tanabe Pharma

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Myasthenia Gravis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Myasthenia Gravis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Myasthenia Gravis Drugs Overall Market Size
2.1 Global Myasthenia Gravis Drugs Market Size: 2021 VS 2027
2.2 Global Myasthenia Gravis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Myasthenia Gravis Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Myasthenia Gravis Drugs Players in Global Market
3.2 Top Global Myasthenia Gravis Drugs Companies Ranked by Revenue
3.3 Global Myasthenia Gravis Drugs Revenue by Companies
3.4 Global Myasthenia Gravis Drugs Sales by Companies
3.5 Global Myasthenia Gravis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Myasthenia Gravis Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Myasthenia Gravis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Myasthenia Gravis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Myasthenia Gravis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Myasthenia Gravis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Myasthenia Gravis Drugs Market Size Markets, 2021 & 2027
4.1.2 Anticholinesterases
4.1.3 Immunosuppressants
4.1.4 Intravenous Immune Globulins
4.2 By Type - Global Myasthenia Gravis Drugs Revenue & Forecasts
4.2.1 By Type - Global Myasthenia Gravis Drugs Revenue, 2016-2021
4.2.2 By Type - Global Myasthenia Gravis Drugs Revenue, 2022-2027
4.2.3 By Type - Global Myasthenia Gravis Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Myasthenia Gravis Drugs Sales & Forecasts
4.3.1 By Type - Global Myasthenia Gravis Drugs Sales, 2016-2021
4.3.2 By Type - Global Myasthenia Gravis Drugs Sales, 2022-2027
4.3.3 By Type - Global Myasthenia Gravis Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Myasthenia Gravis Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Myasthenia Gravis Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Myasthenia Gravis Drugs Revenue & Forecasts
5.2.1 By Application - Global Myasthenia Gravis Drugs Revenue, 2016-2021
5.2.2 By Application - Global Myasthenia Gravis Drugs Revenue, 2022-2027
5.2.3 By Application - Global Myasthenia Gravis Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Myasthenia Gravis Drugs Sales & Forecasts
5.3.1 By Application - Global Myasthenia Gravis Drugs Sales, 2016-2021
5.3.2 By Application - Global Myasthenia Gravis Drugs Sales, 2022-2027
5.3.3 By Application - Global Myasthenia Gravis Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Myasthenia Gravis Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Myasthenia Gravis Drugs Market Size, 2021 & 2027
6.2 By Region - Global Myasthenia Gravis Drugs Revenue & Forecasts
6.2.1 By Region - Global Myasthenia Gravis Drugs Revenue, 2016-2021
6.2.2 By Region - Global Myasthenia Gravis Drugs Revenue, 2022-2027
6.2.3 By Region - Global Myasthenia Gravis Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Myasthenia Gravis Drugs Sales & Forecasts
6.3.1 By Region - Global Myasthenia Gravis Drugs Sales, 2016-2021
6.3.2 By Region - Global Myasthenia Gravis Drugs Sales, 2022-2027
6.3.3 By Region - Global Myasthenia Gravis Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Myasthenia Gravis Drugs Revenue, 2016-2027
6.4.2 By Country - North America Myasthenia Gravis Drugs Sales, 2016-2027
6.4.3 US Myasthenia Gravis Drugs Market Size, 2016-2027
6.4.4 Canada Myasthenia Gravis Drugs Market Size, 2016-2027
6.4.5 Mexico Myasthenia Gravis Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Myasthenia Gravis Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Myasthenia Gravis Drugs Sales, 2016-2027
6.5.3 Germany Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.4 France Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.5 U.K. Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.6 Italy Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.7 Russia Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Myasthenia Gravis Drugs Market Size, 2016-2027
6.5.9 Benelux Myasthenia Gravis Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Myasthenia Gravis Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Myasthenia Gravis Drugs Sales, 2016-2027
6.6.3 China Myasthenia Gravis Drugs Market Size, 2016-2027
6.6.4 Japan Myasthenia Gravis Drugs Market Size, 2016-2027
6.6.5 South Korea Myasthenia Gravis Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Myasthenia Gravis Drugs Market Size, 2016-2027
6.6.7 India Myasthenia Gravis Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Myasthenia Gravis Drugs Revenue, 2016-2027
6.7.2 By Country - South America Myasthenia Gravis Drugs Sales, 2016-2027
6.7.3 Brazil Myasthenia Gravis Drugs Market Size, 2016-2027
6.7.4 Argentina Myasthenia Gravis Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Myasthenia Gravis Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Myasthenia Gravis Drugs Sales, 2016-2027
6.8.3 Turkey Myasthenia Gravis Drugs Market Size, 2016-2027
6.8.4 Israel Myasthenia Gravis Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Myasthenia Gravis Drugs Market Size, 2016-2027
6.8.6 UAE Myasthenia Gravis Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Flamel Technologies
7.1.1 Flamel Technologies Corporate Summary
7.1.2 Flamel Technologies Business Overview
7.1.3 Flamel Technologies Myasthenia Gravis Drugs Major Product Offerings
7.1.4 Flamel Technologies Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Flamel Technologies Key News
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Corporate Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Myasthenia Gravis Drugs Major Product Offerings
7.2.4 F. Hoffmann-La Roche Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.2.5 F. Hoffmann-La Roche Key News
7.3 Grifols
7.3.1 Grifols Corporate Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Myasthenia Gravis Drugs Major Product Offerings
7.3.4 Grifols Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Grifols Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Myasthenia Gravis Drugs Major Product Offerings
7.4.4 Pfizer Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Myasthenia Gravis Drugs Major Product Offerings
7.5.4 Takeda Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Takeda Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Myasthenia Gravis Drugs Major Product Offerings
7.6.4 Novartis Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Bausch Health
7.7.1 Bausch Health Corporate Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Myasthenia Gravis Drugs Major Product Offerings
7.4.4 Bausch Health Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Bausch Health Key News
7.8 Alexion Pharmaceuticals
7.8.1 Alexion Pharmaceuticals Corporate Summary
7.8.2 Alexion Pharmaceuticals Business Overview
7.8.3 Alexion Pharmaceuticals Myasthenia Gravis Drugs Major Product Offerings
7.8.4 Alexion Pharmaceuticals Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Alexion Pharmaceuticals Key News
7.9 Catalyst Pharmaceuticals
7.9.1 Catalyst Pharmaceuticals Corporate Summary
7.9.2 Catalyst Pharmaceuticals Business Overview
7.9.3 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Major Product Offerings
7.9.4 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Catalyst Pharmaceuticals Key News
7.10 CSL
7.10.1 CSL Corporate Summary
7.10.2 CSL Business Overview
7.10.3 CSL Myasthenia Gravis Drugs Major Product Offerings
7.10.4 CSL Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.10.5 CSL Key News
7.11 Curavac
7.11.1 Curavac Corporate Summary
7.11.2 Curavac Myasthenia Gravis Drugs Business Overview
7.11.3 Curavac Myasthenia Gravis Drugs Major Product Offerings
7.11.4 Curavac Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Curavac Key News
7.12 Cytokinetics
7.12.1 Cytokinetics Corporate Summary
7.12.2 Cytokinetics Myasthenia Gravis Drugs Business Overview
7.12.3 Cytokinetics Myasthenia Gravis Drugs Major Product Offerings
7.12.4 Cytokinetics Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Cytokinetics Key News
7.13 Galencia
7.13.1 Galencia Corporate Summary
7.13.2 Galencia Myasthenia Gravis Drugs Business Overview
7.13.3 Galencia Myasthenia Gravis Drugs Major Product Offerings
7.13.4 Galencia Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Galencia Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Myasthenia Gravis Drugs Major Product Offerings
7.14.4 GlaxoSmithKline Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.14.5 GlaxoSmithKline Key News
7.15 Lupin Pharmaceuticals
7.15.1 Lupin Pharmaceuticals Corporate Summary
7.15.2 Lupin Pharmaceuticals Business Overview
7.15.3 Lupin Pharmaceuticals Myasthenia Gravis Drugs Major Product Offerings
7.15.4 Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Lupin Pharmaceuticals Key News
7.16 Mitsubishi Tanabe Pharma
7.16.1 Mitsubishi Tanabe Pharma Corporate Summary
7.16.2 Mitsubishi Tanabe Pharma Business Overview
7.16.3 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Major Product Offerings
7.16.4 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Mitsubishi Tanabe Pharma Key News
8 Global Myasthenia Gravis Drugs Production Capacity, Analysis
8.1 Global Myasthenia Gravis Drugs Production Capacity, 2016-2027
8.2 Myasthenia Gravis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Myasthenia Gravis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Myasthenia Gravis Drugs Supply Chain Analysis
10.1 Myasthenia Gravis Drugs Industry Value Chain
10.2 Myasthenia Gravis Drugs Upstream Market
10.3 Myasthenia Gravis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Myasthenia Gravis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Myasthenia Gravis Drugs in Global Market
Table 2. Top Myasthenia Gravis Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Myasthenia Gravis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Myasthenia Gravis Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Myasthenia Gravis Drugs Sales by Companies, (MT), 2016-2021
Table 6. Global Myasthenia Gravis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Myasthenia Gravis Drugs Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Myasthenia Gravis Drugs Product Type
Table 9. List of Global Tier 1 Myasthenia Gravis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myasthenia Gravis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Flamel Technologies
F. Hoffmann-La Roche
Grifols
Pfizer
Takeda
Novartis
Bausch Health
Alexion Pharmaceuticals
Catalyst Pharmaceuticals
CSL
Curavac
Cytokinetics
Galencia
GlaxoSmithKline
Lupin Pharmaceuticals
Mitsubishi Tanabe Pharma

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE